Combination antiretroviral therapy and MCL-1 inhibition mitigate HTLV-1 infection in vivo
James P. Cooney(The University of Melbourne), Marc Pellegrini(The University of Melbourne), Reet Bhandari(The University of Melbourne), Laura F. Dagley(The University of Melbourne), Lloyd Einsiedel(Alice Springs Hospital), Charis E. Teh(The University of Melbourne), Marcel Doerflinger(The University of Melbourne), Cody C. Allison(The University of Melbourne), Jumana M. Yousef(The University of Melbourne), Geoffrey J. Faulkner(Allen Institute for Brain Science), Natasha Jansz(The University of Queensland), Damian F. J. Purcell(The University of Melbourne), Simon Preston(CS Diagnostics), David Yurick(Peter Doherty Institute), Georges Khoury(The University of Melbourne), William Clow(The University of Melbourne), Philip Arandjelovic(Walter and Eliza Hall Institute of Medical Research), Peter F. Hickey(Walter and Eliza Hall Institute of Medical Research), Tania Tan(Walter and Eliza Hall Institute of Medical Research), Liana Mackiewicz(Walter and Eliza Hall Institute of Medical Research), Daniel H.D. Gray(The University of Melbourne), Stefanie M. Bader(The University of Melbourne), Le Wang(Nanchang University), L.J. Williams(Walter and Eliza Hall Institute of Medical Research), Ashley Hirons(Peter Doherty Institute), Kathryn C. Davidson(Australian Regenerative Medicine Institute), Merle Dayton(Walter and Eliza Hall Institute of Medical Research)
Cited by 14
Related Papers
Mechanism and inhibition of the papain‐like protease, PLpro, of SARS‐CoV‐2
|The EMBO Journal|2020|499
Endogenous Retrotransposition Activates Oncogenic Pathways in Hepatocellular Carcinoma
|Cell|2013|403
IL-7 Engages Multiple Mechanisms to Overcome Chronic Viral Infection and Limit Organ Pathology
|Cell|2011|304
Point Mutations in Exon 1B of APC Reveal Gastric Adenocarcinoma and Proximal Polyposis of the Stomach as a Familial Adenomatous Polyposis Variant
|The American Journal of Human Genetics|2016|265